Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Idogen has successfully completed the optimization of the GMP manufacturing process for the first clinical study with its tolerogenic cell therapy IDO 8

Idogen AB announces today that it has successfully maximized the antigen levels in the cell therapy IDO 8 that the body should learn to recognize and tolerate. This is considered to be an important feature in order to obtain a good treatment effect. The IDO 8 treatment is aiming to create tolerance for ongoing substitution treatment with coagulation factor VIII, a vital drug for hemophilia (hemophilia A) which in many patients is inactivated as a result of undesired immune reactions. The company will shortly submit a clinical trial application to start the first study in patients. Subject

XNK Therapeutics announces study in acute myeloid leukemia (AML) patient samples

December 6th, 2021XNK Therapeutics AB (“XNK”) today announced it will perform a proof of concept study in acute myeloid leukemia (AML) using patient samples from The University of Texas MD Anderson Cancer Center.   The proof of concept study is to determine feasibility to expand and activate NK cells from patients with AML using XNK’s proprietary platform. The goal is to establish patient selection criteria for a clinical trial using XNK’s platform and, ultimately, to develop novel therapeutic approaches for AML patients.   “Autologous treatments have a number of advantages. For

Mandatory notification of trade

On December 3, 2021, primary insiders in Atea ASA completed the following transactions. Steinar Sønsteby exercised 508,693 options in the Company at the average strike price of NOK 70.24.  Following withholding of income taxes, Steinar Sønsteby acquired 375,000 shares in the company. Steinar Sønsteby sold 250,000 shares to Systemintegration ApS at an average price of NOK 162.00. Systemintegration is controlled by Ib Kunøe, who is Chairman of the Board of Atea ASA. The remaining 125,000 shares are to be transferred to SS Holding AS, a personal holding company controlled by Steinar

GET Group AB (publ) signs agreement to enter into the Indonesian geothermal market

GET Group AB (publ) ('GET Group' or 'the Company') has entered into an agreement which allows GET Group to acquire Modular Geothermal Power PTE Ltd ('MGP'), a Singapore and Indonesia based company controlled by a team with strong experience in design, engineering, delivery, and construction of geothermal power plants, having successfully deployed 15 modular power plants producing more than 80MW of power, with specific experience in scalable geothermal modular power plants.GET Group finds the combination of the sub-surface solutions provided by its existing portfolio company Rock Energy and

Moberg Pharma's Chairman Peter Wolpert becomes CEO of Industrifonden and is therefore not available for re-election

Peter Wolpert, Chairman of the Board since 2019 of Moberg Pharma AB (publ), has informed the Nomination Committee that he has been appointed CEO of Industrifonden starting from March 2022. Peter will complete his current term as chairman of the board but will not be available for reelection at the Annual General Meeting in May 2022.Peter Wolpert has been CEO of Moberg Pharma since 2006 and became Chairman of the Board in 2019 in connection with the divestment of Moberg’s commercial OTC operations. "We would like to thank Peter for his valuable contributions to Moberg Pharma as chairman

Mandatory notification of trade

Anooj Unarket, Board member of Otello Corporation ASA, has on behalf of certain related parties, as of 3rd December 2021, acquired interests in shares of Otello Corporation ASA. The balance of Anooj Unarket and related parties’ holdings after the transaction totals 26,449,964 shares. Please refer to the attached notification of trading for further details. This information is subject to disclosure requirements in regulation EU 596/2014 article 19 number 3 and the Norwegian Securities Trading Act section 5-12.

First Camp contemplates issuance of additional bonds

First Camp Group AB has mandated Nordea and Pareto Securities to arrange a series of bond investor meetings starting today, December 6, in order to evaluate an additional tap issue of the bond issued in 2019 and that was increased by SEK 335 million in October 2021.The preliminary amount of the tap issue is SEK 325 million. The amount will be used to finance the acquisition of Jesperhus Feriepark that was announced on December 1, 2021, the acquisition of a smaller campsite in Danmark as well as two other potential acquisitions where due diligence and negotiations are ongoing. The four

Share repurchase update from Catena Media

Catena Media plc repurchased a further 817,700 of its ordinary shares between 17 November and 3 December 2021 as part of a buyback programme that commenced during the third quarter. The repurchases follow a first buyback round executed between 13 September and 15 October 2021, during which Catena Media repurchased 1,504,810 of its ordinary shares. Buybacks will now cease until the holding company has further distributable profits available, in compliance with the requirements of the Maltese Companies Act. Execution of future buybacks will continue to be at the discretion of the board

EQT Exeter to sell modern education property in central Stockholm to Alecta Fastigheter

· EQT Exeter to sell modern education property in central Stockholm to Alecta Fastigheter, the real estate company of the Swedish pension fund manager Alecta  · EQT Exeter has transformed the asset from an obsolete 50 percent vacant Grade C mixed-use building into a sustainable Grade A educational-use property that will host four upper secondary schools for 2,200 students in an attractive and densely populated neighborhood  · The property will meet the standards for BREEAM In-Use “Very Good” with a high emphasis on sustainable and environmentally friendly building techniques such as

Bravida Norway acquires Z-Elektro AS and strengthens its position in electrical installation and service in Telemark

Bravida Norway acquires the company Z-Elektro AS and thereby strengthens its position in the area of electrical installation and service in Telemark. The company has sales of just over NOK 17.5 million and 20 employees.Z-Elektro AS was founded in 2005 by Espen Utzig and is an electrical installation company based in Skien.  “The acquisition significantly strengthens our combined range of services for customers in the Telemark and Vestfold area of Norway, and our ability to deliver good electrical services. All our technology areas within service are currently covered by our Skien branch,

Webstep ASA: Share purchase programme for employees

Oslo, 6 December 2021: The board of directors of Webstep ASA (the "Company") has resolved to implement a share purchase programme for employees in the Company and its subsidiary Webstep AS (the "Share Purchase Programme"), on the basis of the authorisation granted to the board of directors by the extraordinary general meeting of the Company on 23 November 2021.The participants in the Share Purchase Programme will be offered to acquire new shares in the Company for an amount of between NOK 5,000 and NOK 30,000 each (the "Offer"). The shares will be offered at a price equal to the volume

SKF allocates EUR 300 million to green investments

Gothenburg, 6 December 2021: SKF has reached a significant milestone, with a total of EUR 300 million now allocated to investments in accordance with SKF’s Green Finance Framework. The funding comes from the Group’s 10-year Green Bond and is an important part of SKF’s focus on reducing its own emissions as well as increasing investments in R&D, production, testing and remanufacturing capacity for products used in industries such as renewable energy generation, electric vehicles and railway applications.  Niclas Rosenlew, Senior Vice President and CFO, says: “It’s fantastic to be able to

SmartCraft ASA (SMCRT) - The Consti Group chooses SmartCraft to manage their quality and safety work

SmartCraft ASA | Non-regulatory press releases6 December 2021 - The Consti Group (listed on Nasdaq Helsinki) chooses the SmartCraft solution Congrid as their system to manage the quality and safety work at its construction sites. Consti is one of Finland’s leading companies within renovation and technical building services, offering comprehensive renovation and building technology services and selected new construction services to housing companies, corporations, investors and the public sector in Finland’s growth centers. "We have a strong foothold in the Finnish construction market

Swedavia’s traffic statistics for November 2021

In November, more than 1.7 million passengers flew via Swedavia’s ten airports. As a result, for the first time since the start of the pandemic, nearly 60 per cent of passenger volume returned in a single month. However, the pandemic situation, the Omicron variant and new restrictions are creating renew uncertainty about developments in the near term. “The recovery in air travel continued in November, and passenger volume during the month reached the highest level since the start of the pandemic. The easing of restrictions and the EU Digital COVID Certificate facilitate people’s mobility,

Shareholder disclosure by Radforsk Investeringsstiftelse

Reference is made to the stock exchange notice of 4 November 2021 by Targovax ASA ("Targovax") announcing a fully underwritten rights issue of gross proceeds NOK 175 million (the "Rights Issue"), where each existing shareholder as of 25 November 2021 (and being registered as such in the Norwegian Central Securities Depository as at the expiry of 29 November 2021 (the record date)) were granted 1.175114 subscription rights for each share registered as held by the shareholder. Each subscription right gives the right to subscribe for one new share in Targovax. The subscription period

Positive topline results reported for the Phase II COVID-19 clinical trial with the ABNCoV2 vaccine

Hørsholm, Denmark, December 5, 2021 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") announces that the ABNCoV2 vaccine demonstrated a strong boosting effect in the clinical Phase II trial conducted by Bavarian Nordic. The existing levels of SARS-CoV-2 neutralizing antibodies increased by 2-40-fold, depending on the initial levels of antibodies, with no serious adverse events reported. Furthermore, this strong increase was observed to be similar for all variants tested (Wuhan, Alpha, Beta and Delta). The topline results confirm the vaccine’s excellent

Isofol Medical AB (publ) invites to an audiocast on December 6 at 08.00 a.m. CET

GOTHENBURG, Sweden, December 5, 2021 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL), announced on December 3 that the ongoing phase III study AGENT will not reach 300 PFS events with current censoring rules based on FDA decision. Following this announcement, Isofol invites investors, analysts, and media to an audiocast (in English) with a Q&A-session on December 6, at 08:00 a.m. CET.The presentation will be held by Isofol's CEO Ulf Jungnelius and CMO Roger Tell in English and will conclude with a Q&A session. Questions can be asked on the telephone conference or in written form

VALIDATION – ERAS[® ]INTERACTIVE AUDIT SYSTEM

Validation – ERAS[® ]Interactive Audit SystemA validation of Swedish hospitals applying ERAS[® ]through the use of the ERAS[® ]Interactive Audit System (EIAS) was recently published by Ulf Gustafsson et al in the World Journal of Surgery. “Eight hospitals provided complete information for the evaluation, while four hospitals only allowed assessment of coverage and missing data. The average agreement for the assessed postoperative outcome variables was 96.5%. The accuracy was excellent for ‘length of hospital stay,’ ‘reoperation,’ and ‘any complications,’ but lower for

Another great legend awarded the world's most prestigious conservation prize

The Perfect World Award has previously been presented to legends such as Sir David Attenborough, Dr Jane Goodall, Miss Greta Thunberg, and Dr Sylvia Earl. This year, a new icon is Awarded The Perfect World Award “The Conservationist of the Year” – Dr Dian Fossey.The Perfect World Foundation recognises a person who has made significant contributions to the conservation of our natural world with the annual Nordic Wildlife Conservation Award – The Perfect World Award.  This year´s The Perfect World Award “The Conservationist of the Year” goes to Dr Dian Fossey in recognition of her ground-

Nordea Bank Abp: Repurchase of own shares on 03.12.2021

Nordea Bank AbpStock exchange release – Changes in company’s own shares03.12.2021 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 03.12.2021 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading Number of Weighted average Total cost, EUR* **venue (MIC shares price / share, EUR* Code) **XSTO 381,648 10.47 3,996,475.61XHEL 322,362 10.50 3,385,187.83CEUX 324,427 10.49 3,404,156.82AQEU 55,443 10.47

Isofol Medical AB (publ) will not reach 300 PFS events in the AGENT study with current censoring rules based on FDA decision

GOTHENBURG, Sweden, December 3, 2021 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL), announced today that the U.S. Food and Drug Administration (FDA) denied a request from the company to adjust the analysis of the pivotal AGENT study’s secondary endpoint of progression-free survival (PFS). However, the decision will not affect the study’s primary endpoint, objective response rate, previously agreed upon with the FDA. The secondary endpoint may have to be somewhat modified.In the AGENT study, more patients than expected have proceeded to other treatments before they reached tumor

ALEXANDRIA PANKKIIRILIIKE OYJ: ACQUISITION OF OWN SHARES 03.12.2021

ALEXANDRIA PANKKIIRILIIKE OYJ NOTIFICATION 03.12.2021 at 18:30 EET ALEXANDRIA PANKKIIRILIIKE OYJ: ACQUISITION OF OWN SHARES 03.12.2021 Date 03.12.2021Exchange transaction BuyShare class ALEXAmount 401Average price/share 8.0600 EURHighest price/share 8.0600 EURLowest price/share 8.0600 EURTotal price 3,232.06 EUR The shares held by Alexandria Pankkiiriliike Oyj on 03.12.2021: ALEX 41,926 On behalf of Alexandria Pankkiiriliike Oyj  Skandinaviska Enskilda Banken AB (Publ)

Fully subscribed IPO of shares in BPC Instruments AB

LUND, SWEDEN – 3 DECEMBER 2021: On December 1, 2021, the subscription period in BPC Instruments AB (“BPC Instruments” or “the Company”) issue of shares before listing on the Spotlight Stock Market (“Spotlight”) ended. The issue was subscribed to approximately 101 percent, and the Company will thus receive the full amount of approximately SEK 15 million before issue costs amounting to approximately SEK 1.4 million. Through the issue, the Company obtains approximately 400 new shareholders. The first day of trading in BPC Instruments on Spotlight is expected to be December 16, 2021. Sedermera

Terveystalo Plc: SHARE REPURCHASE 3.12.2021

Terveystalo Plc ANNOUNCEMENT  3.12.2021 Terveystalo Plc: SHARE REPURCHASE 3.12.2021 In the Helsinki Stock Exchange Trade date           3.12.2021Bourse trade         BuyShare                  TTALOAmount             28 000 SharesAverage price/ share    10,7713 EURTotal cost            301 596,40 EUR Terveystalo Plc now holds a total of 1 315 534 sharesincluding the shares repurchased on 3.12.2021 On behalf of Terveystalo Plc Nordea Bank Oyj Janne

There are no items matching the current filter
There are no more items matching the current filter
Back to top